Merit Medical Systems' Q4 2023 performance exceeded analyst expectations in both earnings per share and sales, showcasing a significant year-over-year sales growth of 10.59%. This outperformance, especially in a quarter that caps off the fiscal year, is likely to instill investor confidence and could lead to a positive short-term impact on the stock price. The company's ability to not only meet but exceed estimates suggests operational efficiency and a strong market position, factors that investors typically reward.